Coramitug Clinical Trials (2026): 1 Studies for Transthyretin Amyloid Cardiomyopathy
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 Coramitug clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Transthyretin Amyloid Cardiomyopathy) and 14 total planned enrollment. 1 Coramitug clinical trial is actively recruiting. Most recent activity: NCT07448623 (Jul 2028).
Coramitug clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting Coramitug clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07448623 | A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT Imaging in People With ATTR Amyloidosis. | P1 | Transthyretin Amyloid Cardiomyopathy | 14 | Mar 2026 |
All Coramitug trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07448623 | A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT Imaging in People With ATTR Amyloidosis. | P1 | recruiting | 14 | Novo Nordisk A/S | Mar 2026 |
Coramitug clinical trials: frequently asked questions
- How many Coramitug clinical trials are there?
- 1 Coramitug clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are Coramitug clinical trials recruiting in 2026?
- Yes — 1 Coramitug trial is actively recruiting in 2026. See the recruiting trials and the per-state site list further down this page.
- What conditions is Coramitug being studied for?
- Coramitug is being studied for Transthyretin Amyloid Cardiomyopathy. The trials are grouped by indication on this page.
- What phase is Coramitug in?
- Coramitug clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Coramitug clinical trials?
- The lead sponsor across the most Coramitug trials is Novo Nordisk A/S. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Coramitugas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: